BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khan MA, Zubair H, Anand S, Srivastava SK, Singh S, Singh AP. Dysregulation of metabolic enzymes in tumor and stromal cells: Role in oncogenesis and therapeutic opportunities. Cancer Lett 2020;473:176-85. [PMID: 31923436 DOI: 10.1016/j.canlet.2020.01.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Mobet Y, Liu X, Liu T, Yu J, Yi P. Interplay Between m6A RNA Methylation and Regulation of Metabolism in Cancer. Front Cell Dev Biol 2022;10:813581. [DOI: 10.3389/fcell.2022.813581] [Reference Citation Analysis]
2 Bingxiang X, Panxing W, Lu F, Xiuyou Y, Chao D. A Prognostic Model for Brain Glioma Patients Based on 9 Signature Glycolytic Genes. Biomed Res Int 2021;2021:6680066. [PMID: 34222480 DOI: 10.1155/2021/6680066] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Sha L, Lv Z, Liu Y, Zhang Y, Sui X, Wang T, Zhang H. Shikonin inhibits the Warburg effect, cell proliferation, invasion and migration by downregulating PFKFB2 expression in lung cancer. Mol Med Rep 2021;24:560. [PMID: 34109434 DOI: 10.3892/mmr.2021.12199] [Reference Citation Analysis]
4 Pan Y, Tang H, Li Q, Chen G, Li D. Exosomes and their roles in the chemoresistance of pancreatic cancer. Cancer Med 2022. [PMID: 35587712 DOI: 10.1002/cam4.4830] [Reference Citation Analysis]
5 Zafar A, Hasan M, Tariq T, Dai Z. Enhancing Cancer Immunotherapeutic Efficacy with Sonotheranostic Strategies. Bioconjug Chem 2021. [PMID: 34793138 DOI: 10.1021/acs.bioconjchem.1c00437] [Reference Citation Analysis]
6 Ghanavat M, Shahrouzian M, Deris Zayeri Z, Banihashemi S, Kazemi SM, Saki N. Digging deeper through glucose metabolism and its regulators in cancer and metastasis. Life Sci 2021;264:118603. [PMID: 33091446 DOI: 10.1016/j.lfs.2020.118603] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
7 Liu J, Liew SS, Wang J, Pu K. Bioinspired and Biomimetic Delivery Platforms for Cancer Vaccines. Adv Mater 2021;:e2103790. [PMID: 34651344 DOI: 10.1002/adma.202103790] [Reference Citation Analysis]
8 Khan MA, Vikramdeo KS, Sudan SK, Singh S, Wilhite A, Dasgupta S, Rocconi RP, Singh AP. Platinum-resistant ovarian cancer: From drug resistance mechanisms to liquid biopsy-based biomarkers for disease management. Semin Cancer Biol 2021:S1044-579X(21)00217-0. [PMID: 34418576 DOI: 10.1016/j.semcancer.2021.08.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Pardo JC, Ruiz de Porras V, Gil J, Font A, Puig-domingo M, Jordà M. Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer. Nutrients 2022;14:851. [DOI: 10.3390/nu14040851] [Reference Citation Analysis]
10 Sudan SK, Deshmukh SK, Poosarla T, Holliday NP, Dyess DL, Singh AP, Singh S. Resistin: An inflammatory cytokine with multi-faceted roles in cancer. Biochim Biophys Acta Rev Cancer. 2020;1874:188419. [PMID: 32822824 DOI: 10.1016/j.bbcan.2020.188419] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
11 Ang MJY, Chan SY, Goh YY, Luo Z, Lau JW, Liu X. Emerging strategies in developing multifunctional nanomaterials for cancer nanotheranostics. Adv Drug Deliv Rev 2021;:113907. [PMID: 34371084 DOI: 10.1016/j.addr.2021.113907] [Reference Citation Analysis]
12 Zubair H, Khan MA, Anand S, Srivastava SK, Singh S, Singh AP. Modulation of the tumor microenvironment by natural agents: implications for cancer prevention and therapy. Semin Cancer Biol 2020:S1044-579X(20)30105-X. [PMID: 32470379 DOI: 10.1016/j.semcancer.2020.05.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]